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Summary: We report on a 27-year-old healthy female with transient hyperphosphatasaemia of adulthood (it is the
eighth case ever recorded). A maximum alkaline phosphatase activity of 1950 U/l, 11-fold the upper reference limit,
was measured. The activity normalized within 11 weeks. Electrophoresis revealed the typical pattern for alkaline
phosphatase isoenzymes observed in transient hyperphosphatasaemia of infancy: a fast-migrating liver isoenzyme
and a bone isoenzyme. Contrary to the findings in transient hyperphosphatasaemia of infancy the liver isoenzyme
did not precipitate with wheat-germ lectin whereas the bone isoenzyme partially bound to lectin.
Biochemical features of transient hyperphosphatasaemia in an adult may be different from those in infancy. Recogni-
tion of an atypical pattern could help avoid unnecessary extensive investigations.
Introduction
Since the first report published by Assanti et al. (1)
there have been many case reports and a few longer
series dealing with a marked, but transient, increase
of alkaline phosphatase in children (2, 3). Transient
hyperphosphatasaemia in infancy is characterized by a
typical pattern of alkaline phosphatase isoenzymes: a
liver isoenzyme shows an enhanced electrophoretic
mobility and increased binding to wheat-germ lectin
by affinity electrophoresis. The bone isoenzyme, how-
ever, does not show this remarkable increase in mobil-
ity. There is no evidence of liver and bone disease.
The etiology of transient hyperphosphatasaemia re-
mains an enigma.
This syndrome has been also recorded in adults but it
seems a very rare event. Only seven cases have been
published to our knowledge (4—10). A more precise
biochemical characterization of the atypical alkaline
phosphatase isoenzymes was performed in just two
cases (4, 9). Here we report on an eighth adult whose
alkaline phosphatase isoenzymes revealed some bio-




We analyzed sera not only from the adult whose hyperphosphata-
saemia we investigated, but also from infants. These infants
were two boys and two girls, ages nine to 29 months (median
20 months), whose increase in serum alkaline phosphatase had
been noted as an incidental and unexpected finding during the
course of hospital admission for a disorder not normally associ-
ated with such an increase. In order to compare the electropho-
retic mobility of the bone isoenzyme in our adult with that
in different bone diseases, we used sera from 3 patients with
hyperparathyroidism, 3 patients with malignant disease and 1
patient with connective tissue disorder. We used pooled sera
from patients with cholestasis as control serum. Electrophoresis
indicated two well-defined bands, the soluble liver alkaline phos-
phatase isoenzyme (the liver isoenzyme circulating as a soluble
homodimer) and the membrane-bound liver alkaline phosphatase
isoenzyme (the liver isoenzyme anchored to fragments of the
liver cell membrane, often called "high molecular mass liver
isoenzyme", "fast-liver isoenzyme", "bile isoenzyme") (10).
Measurement of total alkaline phosphatase and
electrophoresis of alkaline phosphatase isoenzymes
Measurement of total alkaline phosphatase activity was per-
formed on the automatic chemical analyzer Hitachi 747 (Boeh-
ringer Mannheim, Germany) using />-nitrophenyl phosphate as
substrate at 25 °C (11). Electrophoresis was carried out with
SEBIA agarose gels (SEBIA, Issy-les-Mouligneux, France): the
0.9% agarose gels were used with and without 0.05 g/1 of wheat-
germ lectin. The substrates were indolyl phosphate, MgCl2 and
nitro blue tetrazolium chloride monohydrate in ethanolamine
buffer (pH 9.8). The gels were used with a Tris-barbital buffer
(5.75 g/1 Tris, 1.47 g/1 barbital, 8.24 g/1 sodium barbital and
0.012 g/1 sodium azide, pH 9.1). The gels were scanned at 600
nm with an Appraise densitometer (Beckman, Brea, USA). The
area under the curve and the corresponding isoenzyme activities
were computed by the densitometer.
The within- and between-gel reproducibilities of the scanned
areas under the curve were checked by means of serum pool
controls (total alkaline phosphatase activity 400-800 U/l, isoen-
zyme activities ranged from 7% to 90% of total alkaline phos-
phatase activity). The within-gel variation of the gels with and
without wheat-germ lectin (n = 3) ranged from 1% to 11% and
1% to 9%, respectively. The between-gel variation (n = 3) did
not exceed 9%.
Biochemical characterization of alkaline phosphatase
isoenzymes
For treating the samples with neuraminidase, 20 μΐ of a neur-
aminidase solution from Clostridium perfringens (Beckman,
Brea, USA) were added to 100 μΐ of serum and incubated for
30 minutes at 37 °C. Incubation with polyclonal anti-placental
antiserum (Beckman, Brea, USA) was performed by adding 20 μΐ
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of the antibody solution to 100 μΐ of serum. To resolve protein-
bound isoenzymes as well as polymers of liver isoenzymes of
alkaline phosphatase, 5 μΐ ficin from fig tree latex (Beckman,
Brea, USA) were added to 100 μΐ of serum and incubated for
30 minutes at 37 °C. Serum was treated with α-Ζ,-fucosidase
from bovine kidney: ΙΟμΙ from a fucosidase solution (5—15
units per mg protein at pH 5.5 at 25 °C, Sigma Chemical Co,
St. Louis, USA) were added to 90 μΐ serum. Then, the mixture
was incubated for 24 hours at 37 °C. Inhibition by Z,-phenylala-
nine, L-homoarginine and L-leucine (Sigma, St. Louis, USA)
was determined by addition of these amino acids to the assay
mixture to a final concentration of 5 mmol/1. The percentage
inhibition was calculated with reference to the activity obtained
in the absence of these amino acids. Heat-stability of alkaline
phosphatase was determined as the half-inactivation time of the
enzyme on incubation of 56 °C for various time intervals. After
incubation, samples were immediately put in melting ice in order
to stop the thermodenaturation. The residual activity was then
assayed and the half-inactivation time was determined from a
graph of log (activity) versus time. To identify bone alkaline
phosphatase, electrophoreses of samples after heat inactivation
at 56 °C for 10 minutes were examined.
Results
A 27-year-old female blood donor showed alkaline
phosphatase increasing to 8-fold the upper reference
limit (alkaline phosphatase = 1420 U/l) on October 13,
1995. Remaining laboratory investigations revealed nor-
mal values for electrolytes, alanine and aspartate amino-
transferase, γ-glutamyltransferase, lactate dehydroge-
nase, bilirubin, creatinine, complete blood count, carci-
noembryonic antigen, α-foetoprotein. The woman did
not complain of any symptoms and the physical exami-
nation did not show any abnormalities. Six days later
alkaline phosphatase activity of 1950 U/l was measured,
Agarose gel without wheat-germ
lectin
Agarose gel with wheat-germ lectin
Fig. 1 Densitometric scanning of agarose gels after electropho-
retic separation of alkaline phosphatase isoenzymes. The agarose
gels were used without (left column) and with (right column)
wheat-germ lectin. The samples used were control serum (a), serum
from a 1.3-year-old girl with transient hyperphosphatasaemia (b)
and serum from the 27-year-old female with transient hyperphos-
phatasaemia (c). The arrow indicates the origin.
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11-fold the upper reference limit. At the time two bands
were detected by electrophoresis of alkaline phosphatase
isoenzymes, one sharply defined band with an increased
anodal mobility and one band with a more diffuse ap-
pearance and mobility of bone-derived alkaline phos-
phatase (fig. 1). An alkaline phosphatase activity of 303
U/l was measured on November 14, 1995. The diffuse,
but not the fast-migrating, band had nearly disappeared.
Blood was also drawn from some relatives, i. e. the 29-
year-old sister, the 55-year-old mother and the 63-year-
old father. Normal electrophoretic patterns of the rela-
tives excluded familial inherited hyperphosphatasaemia.
We decided on an extensive clinical examination if a
new blood examination revealed this atypical alkaline
phosphatase isoenzyme again. However, alkaline phos-
phatase activity normalized within 11 weeks (alkaline
phosphatase = 87 U/l on January 29, 1996) and no bio-
chemical abnormality other than the alkaline phospha-
tase electrophoretic pattern of a healthy person could be
found. We diagnosed transient hyperphosphatasaemia.
The atypical fast-migrating band was characterized by a
liver isoenzyme-like half-life of 390 s at 56 °C. It was
not inhibited by L-phenylalanine or L-leucine (3% and
5% inhibition, respectively), but partially by L-homoar-
ginine (26% inhibition). This band did not show any
binding to wheat-germ lectin-agarose, whereas the more
diffuse band identified as a bone isoenzyme was par-
tially affected by wheat-germ lectin-agarose. The fast-
migrating liver isoenzyme of the infants bound to wheat-
germ lectin to a greater (or an equal) extent than the
bone isoenzyme (fig. 1 and tab. 1). The bone isoenzyme
showed a slightly reduced mobility compared to the
bone isoenzymes in the infants and in the patients with
various bone diseases. Neither of the isoenzymes of the
adult reacted to polyclonal anti-placental antiserum or
ficin. Their electrophoretic mobility was clearly reduced
by digestion with neuraminidase.
Tab. 1 Lectin-binding profiles of alkaline phosphatase isoen-




































* Percentage of isoenzyme activity was derived from the densito-
metric scan. Then, percentage as determined by affinity electropho-
resis was divided by percentage as determined by agarose electro-
phoresis without wheat-germ lectin.
Treatment with α-L-fucosidase decreased very slightly
the mobility of the fast-migrating liver isoenzyme in the
adult as well as in the infants. However, the soluble liver
alkaline phosphatase isoenzyme of our control serum
was also slightly retarded.
Discussion
An elevated serum alkaline phosphatase activity in
adults may lead to extensive investigations when com-
mon causes of such an increase can be excluded. Thus,
malignant disease could be the underlying process of an
alkaline phosphatase increase. Transient hyperphospha-
tasaemia has to be considered, but it is a rare phenome-
non. It usually occurs in infants. However, it has also
been observed in adults. Electrophoretic separation of
alkaline phosphatase isoenzymes may uncover for tran-
sient hyperphosphatasaemia an isoenzyme pattern sim-
ilar to that of transient hyperphosphatasaemia in in-
fancy: a fast-migrating liver isoenzyme with an at least
partial binding to wheat-germ lectin (10). Then, the be-
nign nature of transient hyperphosphatasaemia is recog-
nized early and a watch-and-wait policy would be an
acceptable procedure. Our findings in an adult with a
transient hyperphosphatasaemia imply that biochemical
characteristics of the alkaline phosphatase isoenzymes
can differ from the pattern in infants.
Treating the samples with neuraminidase, polyclonal
anti-placental antiserum and ficin, inhibition by some
amino acids, and heat-stability identified the fast-migrat-
ing isoenzyme of our adult as a liver alkaline phospha-
tase isoenzyme. This atypical fast-migrating liver isoen-
zyme did not bind to wheat-germ lectin, whereas the
fast-migrating liver isoenzymes of our infants with a
transient hyperphosphatasaemia showed even a more
substantial binding by affinity electrophoresis than their
bone alkaline phosphatase isoenzymes. This uniform
pattern of lectin-binding within infants contrasts with
the considerable variation in the non-precipitated frac-
tion of the fast-migrating liver alkaline phosphatase.
Crofton demonstrated both liver and bone alkaline phos-
phatase isoenzymes in a transient hyperphosphatasaemia
of infants to be more readily bound by wheat-germ lec-
tin compared with age-matched controls. Furthermore,
there was strong evidence that lectin binding of the alka-
line phosphatase liver isoenzyme correlated very well
with electrophoretic mobility in infants with a transient
hyperphosphatasaemia. This observation corresponds
well with the findings in our infants, but obviously con-
trasts with the situation in our adult. Excessively sialy-
lated isoenzymes might cause the peculiarities in infants.
The high sialic acid content of alkaline phosphatase iso-
enzymes was suggested to provide protection from he-
patic clearance (3). Therefore, the high electrophoretic
mobility of the fast-migrating liver isoenzyme in our
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case cannot be due to the augmented negative charges
of a sialic acid excess. Moreover, ,-fucose, another ter-
minal sugar residue, did not contribute to the increased
mobility as our experiments showed.
Another case of a transient hyperphosphatasaemia in an
adult already revealed a situation different from hyper-
phosphatasaemia of infancy: Onica et al. reported on a
29-year-old man with immune deficiency. His bone al-
kaline phosphatase isoenzyme gave less precipitate with
lectin than the bone isoenzyme of other patients with
increased bone alkaline phosphatase but without evi-
dence of a transient hyperphosphatasaemia (9).
The adult form of a transient hyperphosphatasaemia
could be different from the condition in infants. The
more widespread use of commercially available agarose
gels, which allow affinity electrophoresis of alkaline
phosphatase isoenzymes, will lead rapidly to the diagno-
sis of a transient hyperphosphatasaemia in infants, but
may veil the true nature of this rare phenomenon in
adulthood. The clinical laboratory has to be aware of a
possibly atypical pattern.
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